FDA Approved: MEPSEVII — Supplemental Application (Ultragenyx Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved Ultragenyx's supplemental application for MEPSEVII (vestronidase alfa), approving updates to its labeling for the treatment of mucopolysacchari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Vii

Drugs mentioned

• Mepsevii (vestronidase alfa)

Snippet

SUPPL AP for MEPSEVII (VESTRONIDASE ALFA)